Cargando…
Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application
While mesenchymal stromal cells are an appealing therapeutic option for a range of clinical applications, their potential to induce clotting when used systemically remains a safety concern, particularly in hypercoagulable conditions, such as in patients with severe COVID‐19, trauma, or cancers. Here...
Autores principales: | O'Rourke, Brian, Nguyen, Sunny, Tilles, Arno W., Bynum, James A., Cap, Andrew P., Parekkadan, Biju, Barcia, Rita N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133341/ https://www.ncbi.nlm.nih.gov/pubmed/33527780 http://dx.doi.org/10.1002/sctm.20-0454 |
Ejemplares similares
-
Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells
por: Allen, Ashley, et al.
Publicado: (2020) -
Author Correction: Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells
por: Allen, Ashley, et al.
Publicado: (2020) -
Independent, Controllable Stretch-Perfusion Bioreactor Chambers to Functionalize Cell-Seeded Decellularized Tendons
por: Talò, Giuseppe, et al.
Publicado: (2019) -
Ex vivo conditioning of peripheral blood mononuclear cells of diabetic patients promotes vasculogenic wound healing
por: Tanaka, Rica, et al.
Publicado: (2021) -
Enabling Large‐Scale Ex Vivo Production of Megakaryocytes from CD34(+) Cells Using Gas‐Permeable Surfaces
por: Martinez, Andres F., et al.
Publicado: (2019)